JAMA Cardiology : Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy Among Patients 75 Years or Older
Interview with Richard G. Bach, MD, author of Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial, and Antonio M. Gotto, MD DPhil, author of Intensive Lipid Lowering in Elderly Patients (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - July 17, 2019 Category: General Medicine Source Type: podcasts
Sep 4 Cardiology News
Dr John Mandrola discusses studies from ESC, including CT-FFR, post-PCI bivalirudin, ezetimibe in diabetes, high-sensitivity troponin, resistant HTN, leadless pacing, and afternoon naps. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - September 4, 2015 Category: Cardiology Authors: Medscape Source Type: podcasts
IMPROVE-IT: Are We Back to 'The Lower the Better' for LDL-C?
Seth Bilazarian and Chris Cannon discuss the role of ezetimibe in secondary prevention and whether super-low LDL-C levels are the way to go. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - December 1, 2014 Category: Cardiology Authors: Medscape Source Type: podcasts
ESC on anticoagulants; FDA on Liptruzet; Midei suit; MitraClip
ESC on anticoagulants; FDA approves atorvastatin/ezetimibe combo (Liptruzet) ; Midei suit settled; MitraClip (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - May 10, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#126: Patient care concerns ignored, careers destroyed, claim docs; heart attack deaths plummet in three EU nations; "valve-on-a-stick" transaortic TAVI alternative to transfemoral; Vytorin US label updated; risk begins with middle-age risk factors
Patient care concerns ignored, careers destroyed, claim docs; heart attack deaths plummet in three EU nations; "valve-on-a-stick" transaortic TAVI alternative to transfemoral; Vytorin US label updated; risk begins with middle-age risk factors (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - February 3, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
